Silence Therapeutics PLC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Silence Therapeutics introduces a new equity incentive plan to attract, retain, and motivate key personnel through equity ownership opportunities.